View Older Stories View More Recent Stories

Jun 9, 2025 08:05AM New Study Published in ESMO Open Highlights Guardant Reveal's Performance in Detecting Minimal Residual Disease in Patients with Early-Stage Breast Cancer
Jun 3, 2025 08:05AM Guardant Health (GH) Granted FDA Breakthrough Device Designation for Multi-Cancer Detection (MCD) Test
Jun 3, 2025 08:05AM FDA Grants Breakthrough Device Designation to Guardant Health’s Shield Multi-Cancer Detection (MCD) Test
Jun 2, 2025 08:05AM National Comprehensive Cancer Network (NCCN) Updates Colorectal Cancer Screening Guidelines to Include Shield Blood-Based Screening
Jun 2, 2025 07:00AM SERENA-6 Phase III Trial Demonstrates Clinical Value of Guardant360 CDx Test to Detect Emergence of Endocrine Resistance and Inform a Switch in Therapy Before Radiological Disease Progression in Advan
May 31, 2025 08:05AM In Largest Molecular Residual Disease (MRD) Study in Colon Cancer, Guardant Reveal Testing Prior to Chemotherapy Provides Robust Stratification for Risk of Disease Recurrence and Survival to Enable Ti
May 27, 2025 05:32PM Guardant Health (GH) announces new features for Guardant 360 Liquid test
May 27, 2025 05:30PM Guardant Health Introduces Nearly a Dozen Groundbreaking Smart Liquid Biopsy Applications for Guardant360 Liquid Test
May 22, 2025 05:05PM Guardant Health and Collaborators to Present Over 19 Studies Demonstrating Role of Liquid Biopsy in Advancing Precision Oncology at 2025 ASCO Annual Meeting
May 21, 2025 08:05AM Guardant Health (GH) adds full suite of IHC testing
May 21, 2025 08:05AM Guardant Health Introduces Comprehensive Immunohistochemistry Testing for Solid Tumors
May 20, 2025 08:09AM Guardant Health (GH) Introduces Hereditary Cancer Testing to Identify Inherited Predispositions to Certain Types of Cancer
May 20, 2025 08:05AM Guardant Health Introduces Hereditary Cancer Testing to Identify Inherited Predispositions to Certain Types of Cancer
May 8, 2025 04:05PM Guardant Health to Participate in Upcoming Investor Conferences
May 8, 2025 09:20AM TIME Names Guardant Health Co-CEOs to 2025 TIME100 Health List of the 100 Most Influential People in Global Health This Year
May 7, 2025 05:05PM Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Apr 30, 2025 04:05PM Guardant Health Reports First Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
Apr 29, 2025 04:20PM Guardant Health (GH) Presents Data Demonstrating Strong Performance of Shield Multi-Cancer Detection Test Across 10 Tumor Types
Apr 29, 2025 04:20PM Guardant Health Presents Data Demonstrating Strong Performance of Shield Multi-Cancer Detection Test Across 10 Tumor Types
Apr 28, 2025 08:06AM Guardant Health (GH) Launches Guardant360 Tissue, First Tissue Molecular Profiling Test with Comprehensive Multiomic Analysis to Provide a More Complete View of Cancer
Apr 28, 2025 08:05AM Guardant Health Launches Guardant360 Tissue, First Tissue Molecular Profiling Test with Comprehensive Multiomic Analysis to Provide a More Complete View of Cancer
Apr 24, 2025 08:05AM Guardant Health (GH) Announces Strategic Collaboration With Pfizer to Support Development and Commercialization of New Cancer Therapies Using Guardant Infinity Smart Liquid Biopsy Platform
Apr 24, 2025 08:05AM Guardant Health Announces Strategic Collaboration With Pfizer to Support Development and Commercialization of New Cancer Therapies Using Guardant Infinity Smart Liquid Biopsy Platform
Apr 22, 2025 08:05AM Guardant Health to Present Data Highlighting Advances in Multi-Cancer Detection and Liquid and Tissue Molecular Profiling at AACR
Apr 10, 2025 04:05PM Guardant Health to Report First Quarter 2025 Financial Results on April 30, 2025
Apr 3, 2025 08:08AM Guardant Health (GH) partners with Bayshore HealthCare to offer testing portfolio in Canada
Apr 3, 2025 08:05AM Guardant Health and Bayshore HealthCare Partner to Expand Access to Advanced Precision Oncology Testing in Canada
Mar 25, 2025 04:09PM Guardant Health's (GH) Shield Blood Test Now Covered for VA Community Care Beneficiaries
Mar 25, 2025 04:05PM Guardant Health’s Shield Blood Test Now Covered for VA Community Care Beneficiaries
Mar 11, 2025 07:02AM Guardant Health (GH) Receives ADLT Status From CMS for Shield Blood Test
Mar 11, 2025 07:00AM Guardant Health Receives ADLT Status From CMS for Shield Blood Test
Mar 5, 2025 08:05AM Guardant Health Joins Forces With Dak Prescott’s Faith Fight Finish Foundation and Feist-Weiller Cancer Center’s Partners in Wellness to Boost Colon Cancer Screening in Underserved Communities
Feb 28, 2025 05:05PM Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Feb 27, 2025 08:05AM New Guardant Health/Harris Poll Survey Highlights Patient Fear and Anxiety as Major Barriers to Colorectal Cancer Screening, but Blood Test Option Offers Hope for Change
Feb 20, 2025 04:05PM Guardant Health Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Outlook
Feb 10, 2025 07:00AM Guardant Health to Participate in Upcoming Investor Conferences
Jan 30, 2025 04:05PM Guardant Health to Report Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025
Jan 30, 2025 08:05AM Guardant Health’s Shield Test Selected by Abu Dhabi Department of Health for Blood-Based Colorectal Cancer Screening Program
Jan 23, 2025 08:05AM Guardant Health (GH) to Present Data at ASCO GI Demonstrating the Value of Its Precision Oncology Tools
Jan 23, 2025 08:05AM Guardant Health to Present Data at ASCO GI Demonstrating the Value of Its Precision Oncology Tools for Cancer Detection, Treatment Decisions and Therapy Development
Jan 21, 2025 08:05AM Guardant Health Receives Medicare Coverage for Guardant Reveal™ on Smart Liquid Biopsy™ Platform for Surveillance Testing in Colorectal Cancer Patients
Jan 16, 2025 08:10AM Guardant Health (GH) and ConcertAI Collaborate to Form First Data-As-A-Service That Integrates Clinical and Tumor Profiling Data to Accelerate Cancer Therapy Research and Development
Jan 16, 2025 08:05AM Guardant Health, ConcertAI Collaborate to Form First Data-As-A-Service That Integrates Clinical and Tumor Profiling Data to Accelerate Cancer Therapy Research and Development
Jan 13, 2025 07:00AM Guardant Health Announces Preliminary Fourth Quarter and Full Year 2024 Results
Jan 7, 2025 08:03AM Guardant Health Shield Platform Selected for Inclusion in National Cancer Institute’s Vanguard Study to Evaluate Emerging Technologies for Multi-Cancer Detection
Jan 2, 2025 04:05PM Guardant Health to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Dec 20, 2024 08:05AM Meaningful Insights Biotech Analytics (MiBA) and Guardant Health Announce Strategic Partnership to Optimize Use of Biomarker Testing and Data Analytics to Improve Cancer Care
Dec 19, 2024 06:00AM COTA and Guardant Health Partner to Advance Precision Oncology Research and Therapy Development with Real-World Clinicogenomic Data and AI Analytics
Dec 18, 2024 08:06AM Guardant Health (GH) Announces Collaboration With Boehringer Ingelheim to Develop Companion Diagnostic for Detection of Specific Mutations in Advanced Lung Cancer
Dec 18, 2024 08:05AM Guardant Health Announces Collaboration With Boehringer Ingelheim to Develop Companion Diagnostic for Detection of Specific Mutations in Advanced Lung Cancer
View More Recent Stories View Older Stories